Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

McGill University

$135,000.00

The role of humoral immunity in the acquisition, transmission, and clearance of human papillomavirus infection in heterosexual couples.

FY 2016-17

Summary
Human papillomavirus (HPV) is the most common sexually transmitted infection; over 200 HPV types exist. Most HPV infections clear within a year, but some persist and may result in cervical, vaginal, penile, anal, and mouth and throat cancer. Despite the introduction of costly screening and vaccination programs, HPV is estimated to contribute to 5.2% of the worldwide tumor burden. Hence, HPV prevention needs improvement. Considering that most infections disappear spontaneously, the immune system may have a major role in preventing and clearing HPV infections. It produces antibodies against HPV in response to natural infection or vaccination. Much about this immune response remains unknown: we do not know what triggers the immune system against specific HPV types, its ability to prevent new infections, or how an immune response affects HPV transmission from/to his/her sexual partners. Further, it remains debated whether antibodies against HPV in an individual predict persistent infections or future risk of cancer, or are simply a consequence of past infections. Answers to these questions are important, as (1) they may aid in developing new prevention strategies against HPV-related cancers, and (2) as Canadians become increasingly aware of their HPV status by HPV testing, they would want to be informed about the consequences of an infection. To answer these questions, I will analyze data from the clinical study HITCH, a CIHR-sponsored study of over 500 young, newly formed couples conducted between 2005 and 2013. Baseline demographics, sexual behaviour and HPV infections on genitals, mouth and hands were recorded for 2 years; blood samples were also taken. With these data, I will measure antibody levels against HPV and study their correlation to past, present and future HPV infections, and identify biosocial factors that may affect the immune response. Hence, this study will improve our understanding of the immune response to HPV infections.
Program
CIHR Fellowship
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
362550
Name
Wissing Michel
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
Health Research Training B - HP
Projecttitle
The role of humoral immunity in the acquisition, transmission, and clearance of human papillomavirus infection in heterosexual couples.
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cancer Epidemiology; Cancer Prevention; Cervical Cancer; Cohort Study; Human Papillomavirus (Hpv); Humoral Immunity; Oral Cancer; Sexually Transmitted Infections; Virus Clearance; Virus Transmission
Abstract
Human papillomavirus (HPV) is the most common sexually transmitted infection; over 200 HPV types exist. Most HPV infections clear within a year, but some persist and may result in cervical, vaginal, penile, anal, and mouth and throat cancer. Despite the introduction of costly screening and vaccination programs, HPV is estimated to contribute to 5.2% of the worldwide tumor burden. Hence, HPV prevention needs improvement. Considering that most infections disappear spontaneously, the immune system may have a major role in preventing and clearing HPV infections. It produces antibodies against HPV in response to natural infection or vaccination. Much about this immune response remains unknown: we do not know what triggers the immune system against specific HPV types, its ability to prevent new infections, or how an immune response affects HPV transmission from/to his/her sexual partners. Further, it remains debated whether antibodies against HPV in an individual predict persistent infections or future risk of cancer, or are simply a consequence of past infections. Answers to these questions are important, as (1) they may aid in developing new prevention strategies against HPV-related cancers, and (2) as Canadians become increasingly aware of their HPV status by HPV testing, they would want to be informed about the consequences of an infection. To answer these questions, I will analyze data from the clinical study HITCH, a CIHR-sponsored study of over 500 young, newly formed couples conducted between 2005 and 2013. Baseline demographics, sexual behaviour and HPV infections on genitals, mouth and hands were recorded for 2 years; blood samples were also taken. With these data, I will measure antibody levels against HPV and study their correlation to past, present and future HPV infections, and identify biosocial factors that may affect the immune response. Hence, this study will improve our understanding of the immune response to HPV infections.
Competitiondate
201611
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wissing, Michel
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~